1 Study Coverage 1.1 Penicillin/Streptomycin Product Introduction 1.2 Market by Type 1.2.1 Global Penicillin/Streptomycin Market Size Growth Rate by Type 1.2.2 Penicillin 1.2.3 Streptomycin 1.3 Market by Application 1.3.1 Global Penicillin/Streptomycin Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Penicillin/Streptomycin Market Size, Estimates and Forecasts 2.1.1 Global Penicillin/Streptomycin Revenue 2016-2027 2.1.2 Global Penicillin/Streptomycin Sales 2016-2027 2.2 Global Penicillin/Streptomycin, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Penicillin/Streptomycin Historical Market Size by Region (2016-2021) 2.3.1 Global Penicillin/Streptomycin Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Penicillin/Streptomycin Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Penicillin/Streptomycin Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Penicillin/Streptomycin Sales Forecast by Region (2022-2027) 2.4.2 Global Penicillin/Streptomycin Revenue Forecast by Region (2022-2027) 3 Global Penicillin/Streptomycin Competitor Landscape by Players 3.1 Global Top Penicillin/Streptomycin Manufacturers by Sales 3.1.1 Global Penicillin/Streptomycin Sales by Manufacturer (2016-2021) 3.1.2 Global Penicillin/Streptomycin Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Penicillin/Streptomycin Manufacturers by Revenue 3.2.1 Key Penicillin/Streptomycin Manufacturers Covered: Ranking by Revenue 3.2.2 Global Penicillin/Streptomycin Revenue by Manufacturers (2016-2021) 3.2.3 Global Penicillin/Streptomycin Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Penicillin/Streptomycin Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Penicillin/Streptomycin Revenue in 2020 3.2.6 Global Penicillin/Streptomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Penicillin/Streptomycin Price by Manufacturers 3.4 Global Penicillin/Streptomycin Manufacturing Base Distribution, Product Types 3.4.1 Penicillin/Streptomycin Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Penicillin/Streptomycin Product Type 3.4.3 Date of International Manufacturers Enter into Penicillin/Streptomycin Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Penicillin/Streptomycin Market Size by Type (2016-2021) 4.1.1 Global Penicillin/Streptomycin Sales by Type (2016-2021) 4.1.2 Global Penicillin/Streptomycin Revenue by Type (2016-2021) 4.1.3 Penicillin/Streptomycin Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Penicillin/Streptomycin Market Size Forecast by Type (2022-2027) 4.2.1 Global Penicillin/Streptomycin Sales Forecast by Type (2022-2027) 4.2.2 Global Penicillin/Streptomycin Revenue Forecast by Type (2022-2027) 4.2.3 Penicillin/Streptomycin Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Penicillin/Streptomycin Market Size by Application (2016-2021) 5.1.1 Global Penicillin/Streptomycin Sales by Application (2016-2021) 5.1.2 Global Penicillin/Streptomycin Revenue by Application (2016-2021) 5.1.3 Penicillin/Streptomycin Price by Application (2016-2021) 5.2 Penicillin/Streptomycin Market Size Forecast by Application (2022-2027) 5.2.1 Global Penicillin/Streptomycin Sales Forecast by Application (2022-2027) 5.2.2 Global Penicillin/Streptomycin Revenue Forecast by Application (2022-2027) 5.2.3 Global Penicillin/Streptomycin Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Penicillin/Streptomycin Market Size YoY Growth 2016-2027 6.1.1 Japan Penicillin/Streptomycin Sales YoY Growth 2016-2027 6.1.2 Japan Penicillin/Streptomycin Revenue YoY Growth 2016-2027 6.1.3 Japan Penicillin/Streptomycin Market Share in Global Market 2016-2027 6.2 Japan Penicillin/Streptomycin Market Size by Players (International and Local Players) 6.2.1 Japan Top Penicillin/Streptomycin Players by Sales (2016-2021) 6.2.2 Japan Top Penicillin/Streptomycin Players by Revenue (2016-2021) 6.3 Japan Penicillin/Streptomycin Historic Market Review by Type (2016-2021) 6.3.1 Japan Penicillin/Streptomycin Sales Market Share by Type (2016-2021) 6.3.2 Japan Penicillin/Streptomycin Revenue Market Share by Type (2016-2021) 6.3.3 Japan Penicillin/Streptomycin Price by Type (2016-2021) 6.4 Japan Penicillin/Streptomycin Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Penicillin/Streptomycin Sales Forecast by Type (2022-2027) 6.4.2 Japan Penicillin/Streptomycin Revenue Forecast by Type (2022-2027) 6.4.3 Japan Penicillin/Streptomycin Price Forecast by Type (2022-2027) 6.5 Japan Penicillin/Streptomycin Historic Market Review by Application (2016-2021) 6.5.1 Japan Penicillin/Streptomycin Sales Market Share by Application (2016-2021) 6.5.2 Japan Penicillin/Streptomycin Revenue Market Share by Application (2016-2021) 6.5.3 Japan Penicillin/Streptomycin Price by Application (2016-2021) 6.6 Japan Penicillin/Streptomycin Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Penicillin/Streptomycin Sales Forecast by Application (2022-2027) 6.6.2 Japan Penicillin/Streptomycin Revenue Forecast by Application (2022-2027) 6.6.3 Japan Penicillin/Streptomycin Price Forecast by Application (2022-2027) 7 North America 7.1 North America Penicillin/Streptomycin Market Size YoY Growth 2016-2027 7.2 North America Penicillin/Streptomycin Market Facts & Figures by Country 7.2.1 North America Penicillin/Streptomycin Sales by Country (2016-2021) 7.2.2 North America Penicillin/Streptomycin Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Penicillin/Streptomycin Market Size YoY Growth 2016-2027 8.2 Asia Pacific Penicillin/Streptomycin Market Facts & Figures by Region 8.2.1 Asia Pacific Penicillin/Streptomycin Sales by Region (2016-2021) 8.2.2 Asia Pacific Penicillin/Streptomycin Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Penicillin/Streptomycin Market Size YoY Growth 2016-2027 9.2 Europe Penicillin/Streptomycin Market Facts & Figures by Country 9.2.1 Europe Penicillin/Streptomycin Sales by Country (2016-2021) 9.2.2 Europe Penicillin/Streptomycin Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Penicillin/Streptomycin Market Size YoY Growth 2016-2027 10.2 Latin America Penicillin/Streptomycin Market Facts & Figures by Country 10.2.1 Latin America Penicillin/Streptomycin Sales by Country (2016-2021) 10.2.2 Latin America Penicillin/Streptomycin Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Penicillin/Streptomycin Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Penicillin/Streptomycin Market Facts & Figures by Country 11.2.1 Middle East and Africa Penicillin/Streptomycin Sales by Country (2016-2021) 11.2.2 Middle East and Africa Penicillin/Streptomycin Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Johnson & Johnson 12.1.1 Johnson & Johnson Corporation Information 12.1.2 Johnson & Johnson Description and Business Overview 12.1.3 Johnson & Johnson Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Johnson & Johnson Penicillin/Streptomycin Products Offered 12.1.5 Johnson & Johnson Recent Development 12.2 Pfizer 12.2.1 Pfizer Corporation Information 12.2.2 Pfizer Description and Business Overview 12.2.3 Pfizer Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Pfizer Penicillin/Streptomycin Products Offered 12.2.5 Pfizer Recent Development 12.3 Bayer HealthCare 12.3.1 Bayer HealthCare Corporation Information 12.3.2 Bayer HealthCare Description and Business Overview 12.3.3 Bayer HealthCare Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bayer HealthCare Penicillin/Streptomycin Products Offered 12.3.5 Bayer HealthCare Recent Development 12.4 Abbot Laboratories 12.4.1 Abbot Laboratories Corporation Information 12.4.2 Abbot Laboratories Description and Business Overview 12.4.3 Abbot Laboratories Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Abbot Laboratories Penicillin/Streptomycin Products Offered 12.4.5 Abbot Laboratories Recent Development 12.5 Roche Pharmaceuticals 12.5.1 Roche Pharmaceuticals Corporation Information 12.5.2 Roche Pharmaceuticals Description and Business Overview 12.5.3 Roche Pharmaceuticals Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche Pharmaceuticals Penicillin/Streptomycin Products Offered 12.5.5 Roche Pharmaceuticals Recent Development 12.6 Sanofi Aventis 12.6.1 Sanofi Aventis Corporation Information 12.6.2 Sanofi Aventis Description and Business Overview 12.6.3 Sanofi Aventis Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sanofi Aventis Penicillin/Streptomycin Products Offered 12.6.5 Sanofi Aventis Recent Development 12.7 Takeda Pharmaceutical Company 12.7.1 Takeda Pharmaceutical Company Corporation Information 12.7.2 Takeda Pharmaceutical Company Description and Business Overview 12.7.3 Takeda Pharmaceutical Company Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Takeda Pharmaceutical Company Penicillin/Streptomycin Products Offered 12.7.5 Takeda Pharmaceutical Company Recent Development 12.8 Toyama Chemical 12.8.1 Toyama Chemical Corporation Information 12.8.2 Toyama Chemical Description and Business Overview 12.8.3 Toyama Chemical Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Toyama Chemical Penicillin/Streptomycin Products Offered 12.8.5 Toyama Chemical Recent Development 12.9 Merck & Co. 12.9.1 Merck & Co. Corporation Information 12.9.2 Merck & Co. Description and Business Overview 12.9.3 Merck & Co. Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Merck & Co. Penicillin/Streptomycin Products Offered 12.9.5 Merck & Co. Recent Development 12.10 MiddleBrook Pharmaceuticals 12.10.1 MiddleBrook Pharmaceuticals Corporation Information 12.10.2 MiddleBrook Pharmaceuticals Description and Business Overview 12.10.3 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.10.4 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Products Offered 12.10.5 MiddleBrook Pharmaceuticals Recent Development 12.11 Johnson & Johnson 12.11.1 Johnson & Johnson Corporation Information 12.11.2 Johnson & Johnson Description and Business Overview 12.11.3 Johnson & Johnson Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Johnson & Johnson Penicillin/Streptomycin Products Offered 12.11.5 Johnson & Johnson Recent Development 12.12 Biogen IDEC 12.12.1 Biogen IDEC Corporation Information 12.12.2 Biogen IDEC Description and Business Overview 12.12.3 Biogen IDEC Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Biogen IDEC Products Offered 12.12.5 Biogen IDEC Recent Development 12.13 Bristol Myers Squibb 12.13.1 Bristol Myers Squibb Corporation Information 12.13.2 Bristol Myers Squibb Description and Business Overview 12.13.3 Bristol Myers Squibb Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Bristol Myers Squibb Products Offered 12.13.5 Bristol Myers Squibb Recent Development 12.14 Celgine Corporation 12.14.1 Celgine Corporation Corporation Information 12.14.2 Celgine Corporation Description and Business Overview 12.14.3 Celgine Corporation Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Celgine Corporation Products Offered 12.14.5 Celgine Corporation Recent Development 12.15 Eli Lilly and Co 12.15.1 Eli Lilly and Co Corporation Information 12.15.2 Eli Lilly and Co Description and Business Overview 12.15.3 Eli Lilly and Co Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Eli Lilly and Co Products Offered 12.15.5 Eli Lilly and Co Recent Development 12.16 Gilead Sciences 12.16.1 Gilead Sciences Corporation Information 12.16.2 Gilead Sciences Description and Business Overview 12.16.3 Gilead Sciences Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Gilead Sciences Products Offered 12.16.5 Gilead Sciences Recent Development 12.17 GlaxoSmithKline 12.17.1 GlaxoSmithKline Corporation Information 12.17.2 GlaxoSmithKline Description and Business Overview 12.17.3 GlaxoSmithKline Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.17.4 GlaxoSmithKline Products Offered 12.17.5 GlaxoSmithKline Recent Development 12.18 Amgen 12.18.1 Amgen Corporation Information 12.18.2 Amgen Description and Business Overview 12.18.3 Amgen Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Amgen Products Offered 12.18.5 Amgen Recent Development 12.19 Astellas Pharma 12.19.1 Astellas Pharma Corporation Information 12.19.2 Astellas Pharma Description and Business Overview 12.19.3 Astellas Pharma Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Astellas Pharma Products Offered 12.19.5 Astellas Pharma Recent Development 12.20 Astra Zeneca 12.20.1 Astra Zeneca Corporation Information 12.20.2 Astra Zeneca Description and Business Overview 12.20.3 Astra Zeneca Penicillin/Streptomycin Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Astra Zeneca Products Offered 12.20.5 Astra Zeneca Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Penicillin/Streptomycin Industry Trends 13.2 Penicillin/Streptomycin Market Drivers 13.3 Penicillin/Streptomycin Market Challenges 13.4 Penicillin/Streptomycin Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Penicillin/Streptomycin Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Penicillin/Streptomycin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Penicillin Table 3. Major Manufacturers of Streptomycin Table 4. Global Penicillin/Streptomycin Market Size Growth Rate by Application (2021-2027) & (K Pcs) Table 5. Global Penicillin/Streptomycin Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Penicillin/Streptomycin Sales by Regions (2016-2021) & (K Pcs) Table 7. Global Penicillin/Streptomycin Sales Market Share by Regions (2016-2021) Table 8. Global Penicillin/Streptomycin Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Penicillin/Streptomycin Sales Forecast by Region (2022-2027) & (K Pcs) Table 10. Global Penicillin/Streptomycin Sales Market Share Forecast by Region (2022-2027) Table 11. Global Penicillin/Streptomycin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Penicillin/Streptomycin Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Penicillin/Streptomycin Sales by Manufacturers (2016-2021) (K Pcs) Table 14. Global Penicillin/Streptomycin Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Penicillin/Streptomycin Manufacturers by Revenue (US$ Million) in 2020 Table 16. Penicillin/Streptomycin Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Penicillin/Streptomycin Revenue Share by Manufacturers (2016-2021) Table 18. Global Penicillin/Streptomycin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Penicillin/Streptomycin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Penicillin/Streptomycin as of 2020) Table 20. Key Manufacturers Penicillin/Streptomycin Price (2016-2021) (USD/Pcs) Table 21. Penicillin/Streptomycin Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Penicillin/Streptomycin Product Type Table 23. Date of International Manufacturers Enter into Penicillin/Streptomycin Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Penicillin/Streptomycin Sales by Type (2016-2021) (K Pcs) Table 26. Global Penicillin/Streptomycin Sales Share by Type (2016-2021) Table 27. Global Penicillin/Streptomycin Revenue by Type (2016-2021) (US$ Million) Table 28. Global Penicillin/Streptomycin Revenue Share by Type (2016-2021) Table 29. Penicillin/Streptomycin Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs) Table 30. Global Penicillin/Streptomycin Sales Forecast by Type (2022-2027) & (K Pcs) Table 31. Global Penicillin/Streptomycin Sales Market Share Forecast by Type (2022-2027) Table 32. Global Penicillin/Streptomycin Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Penicillin/Streptomycin Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Penicillin/Streptomycin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs) Table 35. Global Penicillin/Streptomycin Sales by Application (2016-2021) (K Pcs) Table 36. Global Penicillin/Streptomycin Sales Share by Application (2016-2021) Table 37. Global Penicillin/Streptomycin Revenue by Application (2016-2021) (US$ Million) Table 38. Global Penicillin/Streptomycin Revenue Share by Application (2016-2021) Table 39. Penicillin/Streptomycin Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs) Table 40. Global Penicillin/Streptomycin Sales Forecast by Application (2022-2027) & (K Pcs) Table 41. Global Penicillin/Streptomycin Sales Market Share Forecast by Application (2022-2027) Table 42. Global Penicillin/Streptomycin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Penicillin/Streptomycin Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Penicillin/Streptomycin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs) Table 45. Japan Penicillin/Streptomycin Sales (K Pcs) of Key Companies (2016-2021) Table 46. Japan Penicillin/Streptomycin Sales Share by Company (2016-2021) Table 47. Japan Penicillin/Streptomycin Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Penicillin/Streptomycin Revenue Share by Company (2016-2021) Table 49. Japan Penicillin/Streptomycin Sales (K Pcs) by Type (2016-2021) Table 50. Japan Penicillin/Streptomycin Sales Share by Type (2016-2021) Table 51. Japan Penicillin/Streptomycin Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Penicillin/Streptomycin Price (USD/Pcs) by Type (2016-2021) Table 53. Japan Penicillin/Streptomycin Sales (K Pcs) by Type (2022-2027) Table 54. Japan Penicillin/Streptomycin Sales Share by Type (2022-2027) Table 55. Japan Penicillin/Streptomycin Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Penicillin/Streptomycin Revenue Share by Type (2022-2027) Table 57. Japan Penicillin/Streptomycin Price (USD/Pcs) by Type (2022-2027) Table 58. Japan Penicillin/Streptomycin Sales (K Pcs) by Application (2016-2021) Table 59. Japan Penicillin/Streptomycin Sales Share by Application (2016-2021) Table 60. Japan Penicillin/Streptomycin Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Penicillin/Streptomycin Price (USD/Pcs) by Application (2016-2021) Table 62. Japan Penicillin/Streptomycin Sales (K Pcs) by Application (2022-2027) Table 63. Japan Penicillin/Streptomycin Sales Share by Application (2022-2027) Table 64. Japan Penicillin/Streptomycin Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Penicillin/Streptomycin Revenue Share by Application (2022-2027) Table 66. Japan Penicillin/Streptomycin Price (USD/Pcs) by Application (2022-2027) Table 67. North America Penicillin/Streptomycin Sales by Country (2016-2021) & (K Pcs) Table 68. North America Penicillin/Streptomycin Sales Market Share by Country (2016-2021) Table 69. North America Penicillin/Streptomycin Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Penicillin/Streptomycin Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Penicillin/Streptomycin Sales by Region (2016-2021) & (K Pcs) Table 72. Asia Pacific Penicillin/Streptomycin Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Penicillin/Streptomycin Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Penicillin/Streptomycin Revenue Market Share by Region (2016-2021) Table 75. Europe Penicillin/Streptomycin Sales by Country (2016-2021) & (K Pcs) Table 76. Europe Penicillin/Streptomycin Sales Market Share by Country (2016-2021) Table 77. Europe Penicillin/Streptomycin Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Penicillin/Streptomycin Revenue Market Share by Country (2016-2021) Table 79. Latin America Penicillin/Streptomycin Sales by Country (2016-2021) & (K Pcs) Table 80. Latin America Penicillin/Streptomycin Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Penicillin/Streptomycin Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Penicillin/Streptomycin Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Penicillin/Streptomycin Sales by Country (2016-2021) & (K Pcs) Table 84. Middle East and Africa Penicillin/Streptomycin Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Penicillin/Streptomycin Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Penicillin/Streptomycin Revenue Market Share by Country (2016-2021) Table 87. Johnson & Johnson Corporation Information Table 88. Johnson & Johnson Description and Business Overview Table 89. Johnson & Johnson Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 90. Johnson & Johnson Penicillin/Streptomycin Product Table 91. Johnson & Johnson Recent Development Table 92. Pfizer Corporation Information Table 93. Pfizer Description and Business Overview Table 94. Pfizer Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 95. Pfizer Product Table 96. Pfizer Recent Development Table 97. Bayer HealthCare Corporation Information Table 98. Bayer HealthCare Description and Business Overview Table 99. Bayer HealthCare Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 100. Bayer HealthCare Product Table 101. Bayer HealthCare Recent Development Table 102. Abbot Laboratories Corporation Information Table 103. Abbot Laboratories Description and Business Overview Table 104. Abbot Laboratories Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 105. Abbot Laboratories Product Table 106. Abbot Laboratories Recent Development Table 107. Roche Pharmaceuticals Corporation Information Table 108. Roche Pharmaceuticals Description and Business Overview Table 109. Roche Pharmaceuticals Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 110. Roche Pharmaceuticals Product Table 111. Roche Pharmaceuticals Recent Development Table 112. Sanofi Aventis Corporation Information Table 113. Sanofi Aventis Description and Business Overview Table 114. Sanofi Aventis Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Sanofi Aventis Product Table 116. Sanofi Aventis Recent Development Table 117. Takeda Pharmaceutical Company Corporation Information Table 118. Takeda Pharmaceutical Company Description and Business Overview Table 119. Takeda Pharmaceutical Company Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Takeda Pharmaceutical Company Product Table 121. Takeda Pharmaceutical Company Recent Development Table 122. Toyama Chemical Corporation Information Table 123. Toyama Chemical Description and Business Overview Table 124. Toyama Chemical Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. Toyama Chemical Product Table 126. Toyama Chemical Recent Development Table 127. Merck & Co. Corporation Information Table 128. Merck & Co. Description and Business Overview Table 129. Merck & Co. Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. Merck & Co. Product Table 131. Merck & Co. Recent Development Table 132. MiddleBrook Pharmaceuticals Corporation Information Table 133. MiddleBrook Pharmaceuticals Description and Business Overview Table 134. MiddleBrook Pharmaceuticals Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. MiddleBrook Pharmaceuticals Product Table 136. MiddleBrook Pharmaceuticals Recent Development Table 137. Novartis Corporation Information Table 138. Novartis Description and Business Overview Table 139. Novartis Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Novartis Product Table 141. Novartis Recent Development Table 142. Biogen IDEC Corporation Information Table 143. Biogen IDEC Description and Business Overview Table 144. Biogen IDEC Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 145. Biogen IDEC Product Table 146. Biogen IDEC Recent Development Table 147. Bristol Myers Squibb Corporation Information Table 148. Bristol Myers Squibb Description and Business Overview Table 149. Bristol Myers Squibb Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 150. Bristol Myers Squibb Product Table 151. Bristol Myers Squibb Recent Development Table 152. Celgine Corporation Corporation Information Table 153. Celgine Corporation Description and Business Overview Table 154. Celgine Corporation Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 155. Celgine Corporation Product Table 156. Celgine Corporation Recent Development Table 157. Eli Lilly and Co Corporation Information Table 158. Eli Lilly and Co Description and Business Overview Table 159. Eli Lilly and Co Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 160. Eli Lilly and Co Product Table 161. Eli Lilly and Co Recent Development Table 162. Gilead Sciences Corporation Information Table 163. Gilead Sciences Description and Business Overview Table 164. Gilead Sciences Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 165. Gilead Sciences Product Table 166. Gilead Sciences Recent Development Table 167. GlaxoSmithKline Corporation Information Table 168. GlaxoSmithKline Description and Business Overview Table 169. GlaxoSmithKline Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 170. GlaxoSmithKline Product Table 171. GlaxoSmithKline Recent Development Table 172. Amgen Corporation Information Table 173. Amgen Description and Business Overview Table 174. Amgen Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 175. Amgen Product Table 176. Amgen Recent Development Table 177. Astellas Pharma Corporation Information Table 178. Astellas Pharma Description and Business Overview Table 179. Astellas Pharma Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 180. Astellas Pharma Product Table 181. Astellas Pharma Recent Development Table 182. Astra Zeneca Corporation Information Table 183. Astra Zeneca Description and Business Overview Table 184. Astra Zeneca Penicillin/Streptomycin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 185. Astra Zeneca Product Table 186. Astra Zeneca Recent Development Table 187. Penicillin/Streptomycin Market Trends Table 188. Penicillin/Streptomycin Market Drivers Table 189. Penicillin/Streptomycin Market Challenges Table 190. Penicillin/Streptomycin Market Restraints Table 191. Penicillin/Streptomycin Customers List Table 192. Penicillin/Streptomycin Distributors List Table 193. Research Programs/Design for This Report Table 194. Key Data Information from Secondary Sources Table 195. Key Data Information from Primary Sources List of Figures Figure 1. Penicillin/Streptomycin Product Picture Figure 2. Global Penicillin/Streptomycin Sales Market Share by Type in 2020 & 2027 Figure 3. Penicillin Product Picture Figure 4. Streptomycin Product Picture Figure 5. Global Penicillin/Streptomycin Sales Market Share by Application in 2020 & 2027 Figure 6. Hospitals Figure 7. Clinics Figure 8. Others Figure 9. Penicillin/Streptomycin Report Years Considered Figure 10. Global Penicillin/Streptomycin Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Penicillin/Streptomycin Market Size 2016-2027 (US$ Million) Figure 12. Global Penicillin/Streptomycin Sales 2016-2027 (K Pcs) Figure 13. Global Penicillin/Streptomycin Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Penicillin/Streptomycin Sales Market Share by Region (2016-2021) Figure 15. Global Penicillin/Streptomycin Sales Market Share by Region in 2020 Figure 16. Global Penicillin/Streptomycin Revenue Market Share by Region (2016-2021) Figure 17. Global Penicillin/Streptomycin Revenue Market Share by Region in 2020 Figure 18. Global Penicillin/Streptomycin Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Penicillin/Streptomycin Revenue in 2020 Figure 20. Penicillin/Streptomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Penicillin/Streptomycin Sales Market Share by Type (2016-2021) Figure 22. Global Penicillin/Streptomycin Sales Market Share by Type in 2020 Figure 23. Global Penicillin/Streptomycin Revenue Market Share by Type (2016-2021) Figure 24. Global Penicillin/Streptomycin Revenue Market Share by Type in 2020 Figure 25. Global Penicillin/Streptomycin Sales Market Share by Application (2016-2021) Figure 26. Global Penicillin/Streptomycin Sales Market Share by Application in 2020 Figure 27. Global Penicillin/Streptomycin Revenue Market Share by Application (2016-2021) Figure 28. Global Penicillin/Streptomycin Revenue Market Share by Application in 2020 Figure 29. Japan Penicillin/Streptomycin Sales Growth Rate 2016-2027 (K Pcs) Figure 30. Japan Penicillin/Streptomycin Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. Japan Penicillin/Streptomycin Market Share in Global Market 2016-2027 Figure 32. Japan 5 and 10 Largest Penicillin/Streptomycin Players Market Share by Revenue in Penicillin/Streptomycin in 2020 Figure 33. Japan Penicillin/Streptomycin Revenue Share by Type (2016-2021) Figure 34. Japan Penicillin/Streptomycin Revenue Growth Rate by Type in 2016 & 2020 Figure 35. Japan Penicillin/Streptomycin Revenue Share by Application (2016-2021) Figure 36. Japan Penicillin/Streptomycin Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Penicillin/Streptomycin Sales Growth Rate 2016-2021 (K Pcs) Figure 38. North America Penicillin/Streptomycin Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Penicillin/Streptomycin Sales Market Share by Country in 2020 Figure 40. North America Penicillin/Streptomycin Revenue Market Share by Country in 2020 Figure 41. U.S. Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 42. U.S. Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 44. Canada Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Penicillin/Streptomycin Sales Growth Rate 2016-2021 (K Pcs) Figure 46. Europe Penicillin/Streptomycin Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Penicillin/Streptomycin Sales Market Share by Country in 2020 Figure 48. Europe Penicillin/Streptomycin Revenue Market Share by Country in 2020 Figure 49. Germany Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 50. Germany Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 52. France Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 54. U.K. Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 56. Italy Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 58. Russia Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Penicillin/Streptomycin Sales Growth Rate 2016-2021 (K Pcs) Figure 60. Asia Pacific Penicillin/Streptomycin Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Penicillin/Streptomycin Sales Market Share by Region in 2020 Figure 62. Asia Pacific Penicillin/Streptomycin Revenue Market Share by Region in 2020 Figure 63. China Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 64. China Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 66. Japan Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 68. South Korea Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 70. India Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 72. Australia Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 74. Taiwan Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 76. Indonesia Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 78. Thailand Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 80. Malaysia Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 82. Philippines Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 84. Vietnam Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Penicillin/Streptomycin Sales Growth Rate 2016-2021 (K Pcs) Figure 86. Latin America Penicillin/Streptomycin Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Penicillin/Streptomycin Sales Market Share by Country in 2020 Figure 88. Latin America Penicillin/Streptomycin Revenue Market Share by Country in 2020 Figure 89. Mexico Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 90. Mexico Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 92. Brazil Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 94. Argentina Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Penicillin/Streptomycin Sales Growth Rate 2016-2021 (K Pcs) Figure 96. Middle East and Africa Penicillin/Streptomycin Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Penicillin/Streptomycin Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Penicillin/Streptomycin Revenue Market Share by Country in 2020 Figure 99. Turkey Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 100. Turkey Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 102. Saudi Arabia Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. U.A.E Penicillin/Streptomycin Sales Growth Rate (2016-2021) (K Pcs) Figure 104. U.A.E Penicillin/Streptomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Penicillin/Streptomycin Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Johnson & Johnson Pfizer Bayer HealthCare Abbot Laboratories Roche Pharmaceuticals Sanofi Aventis Takeda Pharmaceutical Company Toyama Chemical Merck & Co. MiddleBrook Pharmaceuticals Novartis Biogen IDEC Bristol Myers Squibb Celgine Corporation Eli Lilly and Co Gilead Sciences GlaxoSmithKline Amgen Astellas Pharma Astra Zeneca